Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of August 7, 2025 • 11:31 PM ET
Additional News
As of August 7, 2025 • 11:31 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 08/07/2025 08:45 AM EDT | Zacks | InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates |
| 08/07/2025 07:35 AM EDT | SeekingAlpha | InflaRx reports Q2 results |
| 08/07/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, August 7th, 2025 |
| 08/07/2025 05:31 AM EDT | US Earnings Reports | Expected earnings - InflaRx N.V. |
| 08/04/2025 08:10 AM EDT | Zacks | Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates |
| 07/11/2025 04:24 PM EDT | SeekingAlpha | InflaRx receives Nasdaq notice for non-compliance with minimum bid price rule |
| 05/29/2025 08:15 AM EDT | KlickAnalytics | Outperform Recommendation Issued On IFRX By Raymond James |
| 05/28/2025 06:58 AM EDT | SeekingAlpha | InflaRx plunges on plans to halt studies into lead asset in rare skin disorder |
| 05/07/2025 07:37 AM EDT | SeekingAlpha | InflaRx GAAP EPS of -Euro0.13 |
| 05/07/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Wednesday, May 7th, 2025 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.